1. BodeVet – StablePlate RX® Launching in September at IVECCS 2017

    March 20, 2017

    This September, the world’s first infusable freeze-dried platelet-derived product will be StablePlate RX® for canines.  StablePlate RX® is a shelf-stable hemostatic agent that couples the healing and hemostatic power of platelets with the stability and convenience of other medicines.  BodeVet will release StablePlate RX® on a limited basis at the International Veterinary and Critical Care […]

  2. Rafael Jorda Joins Cellphire, Inc. as Vice President of R&D

    January 2, 2017

    Cellphire, Inc. announced today that Rafael Jorda has joined the company as Vice President of Research & Development.  Mr. Jorda is an internationally experienced scientific leader with more than 25 years of experience in private and public company management spanning three continents. He has managed the R&D, Intellectual Property, Production, and Business Development operations of […]

  3. In Memory of Dr. Arthur Bode

    November 22, 2016

    The Board, Officers and colleagues at Cellphire, Inc., commemorate their colleague Dr. Arthur P. Bode (b. 1953, d. 2016). Eminent in the field of platelet research, and a joy with whom to work. A gentleman and a scholar, he will be sadly missed.Dr. Arthur (Art) Bode had a background of scientific investigation in platelet function […]

  4. Rodman W. Moorhead, III Joins Cellphire, Inc. Board of Directors

    November 1, 2016

    Rodman W. Moorhead, III Joins Cellphire, Inc. Board of DirectorsNOVEMBER 1, 2016 Rockville, MD, November 1, 2016 – Cellphire, Inc. announced today the appointment of Mr. Rodman W. Moorehead, III to its Board of Directors.  Mr. Moorhead retired from Warburg Pincus, a global private equity firm, after a career spanning 37 years. His last position at […]

  5. Cellphire Investors Receive 50% Maryland Biotechnology Investment Incentive Tax Credit

    September 28, 2016

    Cellphire, Inc. announced today that all investors who participated in the $1.3M Cellphire funding round that closed in August have received their Final Tax Credit Certificates from the Maryland Department of Commerce awarding them a 50% refundable tax credit for their investments in Cellphire.  They are now able to claim the tax refund by filing […]

  6. Cellphire Closes $1.3 Million Funding Round

    August 27, 2016

    Cellphire, Inc. announced today that it had closed on a private funding round totaling approximately $1.3 million. The funding came from undisclosed investors and is expected to augment the $69 million commitment to Cellphire by the Biomedical Advanced Research and Development Authority (BARDA) at the U.S. Department of Health and Human Services.  The use of […]

  7. Cellphire WINS Montgomery County Chamber of Commerce Award: Verl Zanders Emerging Business of the Year

    March 7, 2016

    This award is presented to a company on the leading edge of innovation by creating milestones in technology and/or business practices that have enhanced earnings and contributed to the County’s reputation as an outstanding place to do business. – See more at: http://www.montgomerycountychamber.com/events/business-awards-dinner#sthash.uOW7cUkE.dpufVideo URL: https://www.youtube.com/watch?v=X_T327aH6No&feature=youtu.be

  8. UMD Program Approves 15 Technology Product Development Projects Teaming Maryland Companies With System Faculty

    April 1, 2015

    Cellphire Inc., based in Rockville, is developing cell stabilization technologies that also have application in the delivery of therapeutics and labeled reagents in the diagnosis of traumatic brain injuries. The company collaborates with Bogdan Stoica, assistant professor, department of anesthesiology, University of Maryland, Baltimore, to refine and test the efficacy of the company’s technology for […]

  9. Maryland Venture Fund Provides $1,000,000 Investment to Cellphire

    June 13, 2014

    Governor Martin O’Malley and The Maryland Department of Business and Economic Development announced today that Cellphire has received a $1 million investment through the State’s InvestMaryland program. “Supporting entrepreneurs and innovators like those at Cellphire is a central piece of Maryland’s broad support of the startups and small businesses that move our Innovation Economy forward […]

  10. An Overview of Cellphire Technology

    February 13, 2014

    Cellphire’s stabilization technology is based on a unique, patented, methodology for introducing high concentrations of a simple natural sugar (Trehalose) and other small molecular weight compounds into the cellular compartments, enabling stabilization of the cells in a dry state following freeze drying (lyophilization). The basis of the technology is derived from nature. There are plants […]